LabConnect Strengthens Global Presence with New Headquarters in Raleigh-Durham
LabConnect, recognized as the world’s most agile partner in central laboratory solutions, has officially opened its new global headquarters in Raleigh, North Carolina. This strategic location is poised to bolster the company’s presence within the rapidly expanding Research Triangle region, a renowned hub for contract research organizations (CROs), biotechnology firms, and pharmaceutical companies. The new office will serve as a pivotal base for executive leadership, as well as the commercial, operational, and technological teams, further supporting an increasing portfolio of complex clinical trials worldwide.
The significance of Raleigh-Durham lies in its designation as one of the country's most vibrant life sciences ecosystems. It boasts prestigious research universities, a highly skilled workforce, and a dense network of CROs, biotechnology enterprises, and pharmaceutical organizations. LabConnect's establishment in this strategic area is anticipated to enhance collaboration with sponsors and partner CROs, accelerate innovation in central laboratory services, and create new opportunities for advanced sample management, data integration, and technology solutions—all while maintaining close connections with clients.
Wes Wheeler, the CEO of LabConnect, underscored the importance of this new office by stating, "This new office in Raleigh places us exactly where our clients make some of their most crucial drug development decisions. RDU has become one of the world’s major pharmaceutical innovation hubs. By enhancing our presence here, we can forge even closer partnerships with our clients, attract exceptional talent, and accelerate the development of new medications for patients in need."
Expanding from a network of seven operational sites across North America, Latin America, Europe, the United Kingdom, Australia, China, and South Korea, the Raleigh office will complement LabConnect’s existing capabilities. The alignment of LabConnect’s operational sites with those of its regional partners will strategically enhance the company's scientific, operational, and data capabilities to meet the evolving needs of emerging biopharmaceutical clients.
In the coming years, LabConnect plans to grow its Raleigh office by recruiting additional staff in business development, project management, scientific operations, technology, and data science. This investment reflects the company’s commitment to creating a modern and collaborative work environment that leverages the strengths of the RDU market, all while sustaining its global 'asset-light' operating model and flexible partner laboratory network.
About LabConnect
LabConnect is redefining central laboratory services as a technology partner for pharmaceutical and biotechnology companies. Their decentralized network model allows sponsors access to the most comprehensive testing menu in the industry, backed by advanced sample tracking, data management, and expert consulting services. Through its 'asset-light' approach encompassing functional service provider solutions, specialty testing, and ancillary support, LabConnect provides scalability and efficiency that transcends traditional laboratory outsourcing limitations. By building the laboratory network of the future, LabConnect fosters more precise, agile, and swift development of life-changing treatments. For more information, follow them on LinkedIn or visit www.labconnect.com.
The significance of Raleigh-Durham lies in its designation as one of the country's most vibrant life sciences ecosystems. It boasts prestigious research universities, a highly skilled workforce, and a dense network of CROs, biotechnology enterprises, and pharmaceutical organizations. LabConnect's establishment in this strategic area is anticipated to enhance collaboration with sponsors and partner CROs, accelerate innovation in central laboratory services, and create new opportunities for advanced sample management, data integration, and technology solutions—all while maintaining close connections with clients.
Wes Wheeler, the CEO of LabConnect, underscored the importance of this new office by stating, "This new office in Raleigh places us exactly where our clients make some of their most crucial drug development decisions. RDU has become one of the world’s major pharmaceutical innovation hubs. By enhancing our presence here, we can forge even closer partnerships with our clients, attract exceptional talent, and accelerate the development of new medications for patients in need."
Expanding from a network of seven operational sites across North America, Latin America, Europe, the United Kingdom, Australia, China, and South Korea, the Raleigh office will complement LabConnect’s existing capabilities. The alignment of LabConnect’s operational sites with those of its regional partners will strategically enhance the company's scientific, operational, and data capabilities to meet the evolving needs of emerging biopharmaceutical clients.
In the coming years, LabConnect plans to grow its Raleigh office by recruiting additional staff in business development, project management, scientific operations, technology, and data science. This investment reflects the company’s commitment to creating a modern and collaborative work environment that leverages the strengths of the RDU market, all while sustaining its global 'asset-light' operating model and flexible partner laboratory network.
About LabConnect
LabConnect is redefining central laboratory services as a technology partner for pharmaceutical and biotechnology companies. Their decentralized network model allows sponsors access to the most comprehensive testing menu in the industry, backed by advanced sample tracking, data management, and expert consulting services. Through its 'asset-light' approach encompassing functional service provider solutions, specialty testing, and ancillary support, LabConnect provides scalability and efficiency that transcends traditional laboratory outsourcing limitations. By building the laboratory network of the future, LabConnect fosters more precise, agile, and swift development of life-changing treatments. For more information, follow them on LinkedIn or visit www.labconnect.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.